Nazo-spray (oxymetazoline) nasal spray 0.5 mg/ml. 15 ml.

$8.00

Acute respiratory diseases accompanied by nasal congestion. Allergic rhinitis. Vasomotor rhinitis. To restore drainage and nasal breathing in diseases of the paranasal sinuses of the nasal cavity, Eustachian. To eliminate edema before diagnostic manipulations in the nasal passages.

Category:

Description

Nazo-Spray composition
Active ingredient: oxymetazoline hydrochloride (0.5 mg / ml).
Excipients: polyethylene glycol, benzalkonium chloride, disodium edetate, sodium dihydrogen phosphate dihydrate, water, racemic camphor, racemic menthol, eucalyptol, sodium hydroxide or hydrochloric acid.

Release form
Available as a solution (nasal spray).

Pharmacological properties
This is a nasal spray. The active ingredient excites alpha-adrenergic receptors. When applied to the mucous membrane, it causes vasoconstriction, while reducing edema and redness. With rhinitis (runny nose), relieves nasal breathing.

Indications
Nazo-Spray is used for swelling of the nasal mucosa due to colds, coryza attacks with a large amount of liquid mucous secretions (vasomotor rhinitis), as well as allergic rhinitis, acute sinusitis.
In addition, it is indicated for acute otitis media (to restore the patency of the Eustachian tube).
It is also used to facilitate rhinoscopy.

Contraindications:

  • with allergies to the components of the solution;
  • with “dry” inflammation of the nasal mucosa with the formation of crusts (dry rhinitis);
  • with the transferred transsphenoidal removal of the pituitary gland or any other surgical interventions with a history of exposure of the meninges;
  • with tachycardia;
  • with arterial hypertension;
  • with angina pectoris;
  • with severe atherosclerosis;
  • during pregnancy, breastfeeding;
  • with simultaneous treatment with MAOIs, tricyclic antidepressants;
  • children under six years old.

Use with caution:

  • when treating MAOIs or other drugs with a hypertensive effect in the past;
  • with increased intraocular pressure, especially with angle-closure glaucoma;
  • with cardiovascular pathology;
  • with pheochromocytoma;
  • with metabolic disorders (for example, diabetes mellitus, hyperthyroidism);
  • with porphyria;
  • with prostatic hyperplasia.

Children
It is used in pediatrics for children from 6 years old.

Application during pregnancy and lactation
During these periods, Nazo-Spray is not used.

Method of administration and dosage
Naso-Spray is applied intranasally (in the nose).
The spray is used in children from 6 years old and in adults – one injection into each nasal passage up to three times a day.
It is not recommended to use the spray for more than five days.

Overdose
When applied topically, overdose is unlikely.
Symptoms: mydriasis (dilated pupils), nausea, cyanosis, convulsions, fever, cardiovascular disorders (tachycardia, arterial hypertension, arrhythmia, cardiac arrest), respiratory failure, changes in consciousness, drowsiness, pulmonary edema, decreased body temperature, bradycardia (decrease heart rate), a sharp drop in blood pressure, respiratory arrest, coma development.
Overdose treatment: stopping treatment, seeking medical attention immediately, intensive care.

Side effects:

  • Cardiovascular disorders: heart palpitations, arrhythmias, arterial hypertension.
  • Neurological disorders: headache, paroxysm, insomnia, fatigue, dizziness.
  • Respiratory, thoracic, mediastinal disorders: burning sensation in the nose, feeling of dryness, shortness of breath, sneezing, increased swelling of the nasal mucosa, epistaxis, atrophy of the nasal mucosa.
  • General disorders: tachyphylaxis, fatigue, drowsiness, visual impairment.
  • Digestive disorders: nausea.
  • Immune disorders: hypersensitivity reactions (angioedema, exanthema, itching).
  • Mental disorders: sleep disturbances, agitation, hallucinations.

Storage conditions and periods
Store Nazo-Spray at a temperature of 15-25 ° C out of the reach of children. The spray has a shelf life of two years.